2016
DOI: 10.1016/j.bone.2016.01.010
|View full text |Cite
|
Sign up to set email alerts
|

Proinflammatory T cells and IL-17 stimulate osteoblast differentiation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

7
89
0
4

Year Published

2016
2016
2023
2023

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 149 publications
(100 citation statements)
references
References 74 publications
(93 reference statements)
7
89
0
4
Order By: Relevance
“…During normal bone fracture healing, bone-promoting growth factors are supported by factors associated with the inflammatory response (Cho et al, 2002;Mountziaris et al, 2011;Rundle et al, 2006). Similarly, we previously observed in vitro that proinflammatory mediators require a second, osteogenic stimulus in order to contribute to osteogenesis Croes et al, 2016). This agrees with the current finding that the co-delivery of these factors creates a potent stimulus for new bone formation.…”
Section: Croes Et Alsupporting
confidence: 91%
See 2 more Smart Citations
“…During normal bone fracture healing, bone-promoting growth factors are supported by factors associated with the inflammatory response (Cho et al, 2002;Mountziaris et al, 2011;Rundle et al, 2006). Similarly, we previously observed in vitro that proinflammatory mediators require a second, osteogenic stimulus in order to contribute to osteogenesis Croes et al, 2016). This agrees with the current finding that the co-delivery of these factors creates a potent stimulus for new bone formation.…”
Section: Croes Et Alsupporting
confidence: 91%
“…While several lines of evidence show that TNF-α stimulates the osteoblast differentiation in human MSCs, this effect seems receptor-specific for the TLR agonists Fiedler et al, 2013;Hess et al, 2009). Furthermore, in vitro, pro-inflammatory mediators only promote osteoblast differentiation in the presence of an osteoinductive factor like dexamethasone or BMP-2, suggesting that the commitment of bone progenitor cells to the osteogenic lineage enhances their responsiveness to inflammatory signals Croes et al, 2016;Tomchuck et al, 2008).…”
Section: Croes Et Almentioning
confidence: 99%
See 1 more Smart Citation
“…IL-17 can inhibit the chondrogenic differentiation of MSCs via the suppression of a key chondrogenesis transcriptional factor, SRY-box 9 (SOX9) and its activator cAMP-dependent protein kinase (PKA) [87]. Additionally, an in vitro work showed that IL-17 also enhances the MSC differentiation into osteoblasts [88]. This all indicates that adaptive lymphocytes can actively participate in the endochondral ossification.…”
Section: Repair Phasementioning
confidence: 99%
“…IL-17 induces inflammation through the recruitment and activation of immune cells, leading to the release of proinflammatory molecules, such as IL-1 and TNFα, which increase RANKL expression and synergize with RANKL signaling to maximize osteoclast formation [7,31]. However, Croes et al showed that IL-17A and IL-17F exhibit strong osteogenic effects when exposed directly to MSCs [32]. Similar to previous studies [12,33], we found that SOST reduced the expression of collagen, OCN, and OPN, which was accompanied with the increased expression of LPL and PPARγ.…”
Section: Il17mentioning
confidence: 99%